LENZ Therapeutics, Inc. (LENZ) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
LENZ EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LENZ Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 97.8% | -477.5% | -430.3% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | 100.0% | -69.9% | -72.1% |
| 2021 | - | - | - |
Download Data
Export LENZ earnings history in CSV or JSON format
Free sign-in required to download data
LENZ Therapeutics, Inc. (LENZ) Earnings Overview
As of May 8, 2026, LENZ Therapeutics, Inc. (LENZ) reported trailing twelve-month net income of -$82M, reflecting -21.8% year-over-year growth. The company earned $-2.64 per diluted share over the past four quarters, with a net profit margin of -430.3%.
Looking at the long-term picture, LENZ's historical earnings data spans multiple years. The company achieved its highest annual net income of -$109,000 in fiscal 2019.
LENZ Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRPH (-$42M net income, -788.2% margin), KALA (-$36M net income), NKTR (-$164M net income, -297.1% margin), LENZ has outperformed on profitability metrics. Compare LENZ vs PRPH →
LENZ Earnings vs Peers
Earnings metrics vs comparable public companies
LENZ Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$82M | -65.0% | -$91M | $-2.85 | -430.3% | -477.5% |
| 2024 | -$50M | +28.9% | -$59M | $-2.34 | - | - |
| 2023 | -$70M | -547.2% | -$72M | $-15.30 | - | - |
| 2022 | -$11M | +84.7% | -$10M | $-12.89 | -72.1% | -69.9% |
| 2021 | -$71M | -3.5% | -$60M | $-8.54 | - | - |
| 2020 | -$68M | -62627.5% | -$14M | $-8.24 | - | - |
| 2019 | $-109,000 | - | $-29,000 | $-0.01 | - | - |
See LENZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LENZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LENZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLENZ — Frequently Asked Questions
Quick answers to the most common questions about buying LENZ stock.
Is LENZ growing earnings?
LENZ EPS fell to $-2.64, with earnings declining -21.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-82M.
What are LENZ's profit margins?
LENZ Therapeutics, Inc. net margin is -430.3%, with operating margin at -477.5%. Below-average margins reflect competitive or cost pressures.
How consistent are LENZ's earnings?
LENZ earnings data spans 2019-2025. The declining earnings trend is -21.8% YoY. Historical data enables comparison across business cycles.